Warner, B. M., Vendramelli, R., Boese, A. S., Audet, J., Tailor, N., Meilleur, C., Glowach, N., Willman, M., Truong, T., Moffat, E., Tierney, K., Kosak, B., Dhanidina, I., Engstrom, J., Korczak, B., McGowan, I., Embury-Hyatt, C., Kobasa, D. (2025). Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. PLoS ONE. https://doi.org/10.1371/journal.pone.0316952